Wang ZY - Search Results

1

Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase-deficient renal cell carcinoma.

Zheng L, Zhu ZR, Sneh T, Zhang WT, Wang ZY, Wu GY, He W, Qi HG, Wang H, Wu XY, Fernández-García J, Abramovich I, Xu YZ, Zhang J, Gottlieb E. Zheng L, et al. Among authors: wang h, wang zy. J Clin Invest. 2023 Jun 1;133(11):e165028. doi: 10.1172/JCI165028. J Clin Invest. 2023. PMID: 37053010 Free PMC article.

2

Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.

Xu Y, Kong W, Cao M, Wang J, Wang Z, Zheng L, Wu X, Cheng R, He W, Yang B, Dong B, Pan J, Chen Y, Huang J, Jiang C, Zhai W, Li F, Chen R, Zhou X, Wu G, Geng X, Chen J, An H, Yuan Y, Xu T, Chen D, Lin D, Xu L, Huang K, Peng L, Yu Y, Tai S, Qi H, Luo K, Kang X, Wang H, Huang Y, Zhang J, Xue W. Xu Y, et al. Eur Urol. 2023 Feb;83(2):163-172. doi: 10.1016/j.eururo.2022.05.029. Epub 2022 Jun 15. Eur Urol. 2023. PMID: 35715365

3

Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.

Yin X, Wang Z, Wang J, Xu Y, Kong W, Zhang J. Yin X, et al. Oncoimmunology. 2021 Jun 30;10(1):1933332. doi: 10.1080/2162402X.2021.1933332. eCollection 2021. Oncoimmunology. 2021. PMID: 34262797 Free PMC article.

4

Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.

Cai W, Wang Z, Cai B, Yuan Y, Kong W, Zhang J, Chen Y, Liu Q, Huang Y, Huang J, Xue W. Cai W, et al. Int J Clin Oncol. 2020 Feb;25(2):338-346. doi: 10.1007/s10147-019-01564-1. Epub 2019 Nov 13. Int J Clin Oncol. 2020. PMID: 31720994 Clinical Trial.

5

circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.

Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W. Liu H, et al. Theranostics. 2020 Aug 29;10(23):10791-10807. doi: 10.7150/thno.47239. eCollection 2020. Theranostics. 2020. PMID: 32929380 Free PMC article.

6

Erratum: circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum.

Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W. Liu H, et al. Theranostics. 2022 Jan 1;12(3):1335-1336. doi: 10.7150/thno.69378. eCollection 2022. Theranostics. 2022. PMID: 35154491 Free PMC article.

7

Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study.

Su R, Chen Z, Hong D, Jiang S, Yuan Y, Cai X, Hu H, Fu C, Huang Z, Wang Z, Zheng B, Huang J, Wang Z, Bao Y, Cai M, Guo J, Chen M, Wei Q, Huang J, Xue W. Su R, et al. Cancer Med. 2023 May;12(9):10587-10596. doi: 10.1002/cam4.5796. Epub 2023 Mar 23. Cancer Med. 2023. PMID: 36952461 Free PMC article.

8

The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy.

Huang J, Su R, Chen Z, Jiang S, Chen M, Yuan Y, Hu H, Fu C, Huang Z, Wang Z, Zheng B, Li C, Wang Z, Bao Y, Cai M, Guo J, Wei Q, Xue W. Huang J, et al. Oncoimmunology. 2022 Sep 17;11(1):2124691. doi: 10.1080/2162402X.2022.2124691. eCollection 2022. Oncoimmunology. 2022. PMID: 36148322 Free PMC article.

9

Effect of Cytochrome P450 3A4 on Tissue Distribution of Humantenmine, Koumine, and Gelsemine, three Alkaloids from the Toxic Plant Gelsemium.

Long JY, Wang ZY, Zuo MT, Huang SJ, Xiao-Ma, Qi XJ, Huang CY, Liu ZY. Long JY, et al. Among authors: wang zy. Toxicol Lett. 2024 May 9:S0378-4274(24)00088-2. doi: 10.1016/j.toxlet.2024.05.002. Online ahead of print. Toxicol Lett. 2024. PMID: 38734219

10

The Single Cell Immunogenomic Landscape after Neoadjuvant Immunotherapy combined Chemotherapy in Esophageal Squamous Cell Carcinoma.

Wang ZY, Zhao Y, Wo Y, Peng YZ, Hu WL, Wu ZG, Liu PC, Shang Y, Liu CN, Chen X, Huang K, Chen YT, Hong H, Li F, Sun YH. Wang ZY, et al. Cancer Lett. 2024 May 9:216951. doi: 10.1016/j.canlet.2024.216951. Online ahead of print. Cancer Lett. 2024. PMID: 38734159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,813 results

Search Page